Antiviral drug packaging is specially designed for packaging antiviral drugs. Antiviral drugs are a class of medication used specifically for treating viral infections such as influenza, herpes virus infections, viral hepatitis and human immunodeficiency virus.
The global market for Antiviral Drug Packaging was estimated to be worth US$ 26500 million in 2023 and is forecast to a readjusted size of US$ 34130 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antiviral Drug Packaging, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antiviral Drug Packaging by region & country, by Type, and by Application.
The Antiviral Drug Packaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drug Packaging.
Market Segmentation
By Company
Avery Dennison Corporation
E.I. du Pont de Nemours
CCL Industries Inc
BioCote
Avient
Mondi
Biomaster
BASF
Lonza
Takex Labo Co. Ltd
Berry
Lageen Tubes.
Segment by Type:
Rigid Plastic
Flexible Blister Foils
Others
Segment by Application
Pharmaceuticals
Healthcare
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antiviral Drug Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antiviral Drug Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antiviral Drug Packaging in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Antiviral Drug Packaging Product Introduction
1.2 Global Antiviral Drug Packaging Market Size Forecast
1.2.1 Global Antiviral Drug Packaging Sales Value (2019-2030)
1.2.2 Global Antiviral Drug Packaging Sales Volume (2019-2030)
1.2.3 Global Antiviral Drug Packaging Sales Price (2019-2030)
1.3 Antiviral Drug Packaging Market Trends & Drivers
1.3.1 Antiviral Drug Packaging Industry Trends
1.3.2 Antiviral Drug Packaging Market Drivers & Opportunity
1.3.3 Antiviral Drug Packaging Market Challenges
1.3.4 Antiviral Drug Packaging Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Antiviral Drug Packaging Players Revenue Ranking (2023)
2.2 Global Antiviral Drug Packaging Revenue by Company (2019-2024)
2.3 Global Antiviral Drug Packaging Players Sales Volume Ranking (2023)
2.4 Global Antiviral Drug Packaging Sales Volume by Company Players (2019-2024)
2.5 Global Antiviral Drug Packaging Average Price by Company (2019-2024)
2.6 Key Manufacturers Antiviral Drug Packaging Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Antiviral Drug Packaging Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Antiviral Drug Packaging
2.9 Antiviral Drug Packaging Market Competitive Analysis
2.9.1 Antiviral Drug Packaging Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Antiviral Drug Packaging Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Packaging as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Rigid Plastic
3.1.2 Flexible Blister Foils
3.1.3 Others
3.2 Global Antiviral Drug Packaging Sales Value by Type
3.2.1 Global Antiviral Drug Packaging Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Antiviral Drug Packaging Sales Value, by Type (2019-2030)
3.2.3 Global Antiviral Drug Packaging Sales Value, by Type (%) (2019-2030)
3.3 Global Antiviral Drug Packaging Sales Volume by Type
3.3.1 Global Antiviral Drug Packaging Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Antiviral Drug Packaging Sales Volume, by Type (2019-2030)
3.3.3 Global Antiviral Drug Packaging Sales Volume, by Type (%) (2019-2030)
3.4 Global Antiviral Drug Packaging Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceuticals
4.1.2 Healthcare
4.2 Global Antiviral Drug Packaging Sales Value by Application
4.2.1 Global Antiviral Drug Packaging Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Antiviral Drug Packaging Sales Value, by Application (2019-2030)
4.2.3 Global Antiviral Drug Packaging Sales Value, by Application (%) (2019-2030)
4.3 Global Antiviral Drug Packaging Sales Volume by Application
4.3.1 Global Antiviral Drug Packaging Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Antiviral Drug Packaging Sales Volume, by Application (2019-2030)
4.3.3 Global Antiviral Drug Packaging Sales Volume, by Application (%) (2019-2030)
4.4 Global Antiviral Drug Packaging Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Antiviral Drug Packaging Sales Value by Region
5.1.1 Global Antiviral Drug Packaging Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Antiviral Drug Packaging Sales Value by Region (2019-2024)
5.1.3 Global Antiviral Drug Packaging Sales Value by Region (2025-2030)
5.1.4 Global Antiviral Drug Packaging Sales Value by Region (%), (2019-2030)
5.2 Global Antiviral Drug Packaging Sales Volume by Region
5.2.1 Global Antiviral Drug Packaging Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Antiviral Drug Packaging Sales Volume by Region (2019-2024)
5.2.3 Global Antiviral Drug Packaging Sales Volume by Region (2025-2030)
5.2.4 Global Antiviral Drug Packaging Sales Volume by Region (%), (2019-2030)
5.3 Global Antiviral Drug Packaging Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Antiviral Drug Packaging Sales Value, 2019-2030
5.4.2 North America Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Antiviral Drug Packaging Sales Value, 2019-2030
5.5.2 Europe Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Antiviral Drug Packaging Sales Value, 2019-2030
5.6.2 Asia Pacific Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Antiviral Drug Packaging Sales Value, 2019-2030
5.7.2 South America Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Antiviral Drug Packaging Sales Value, 2019-2030
5.8.2 Middle East & Africa Antiviral Drug Packaging Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Antiviral Drug Packaging Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Antiviral Drug Packaging Sales Value
6.2.1 Key Countries/Regions Antiviral Drug Packaging Sales Value, 2019-2030
6.2.2 Key Countries/Regions Antiviral Drug Packaging Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Antiviral Drug Packaging Sales Value, 2019-2030
6.3.2 United States Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Antiviral Drug Packaging Sales Value, 2019-2030
6.4.2 Europe Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Antiviral Drug Packaging Sales Value, 2019-2030
6.5.2 China Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030
6.5.3 China Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Antiviral Drug Packaging Sales Value, 2019-2030
6.6.2 Japan Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Antiviral Drug Packaging Sales Value, 2019-2030
6.7.2 South Korea Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Antiviral Drug Packaging Sales Value, 2019-2030
6.8.2 Southeast Asia Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Antiviral Drug Packaging Sales Value, 2019-2030
6.9.2 India Antiviral Drug Packaging Sales Value by Type (%), 2023 VS 2030
6.9.3 India Antiviral Drug Packaging Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Avery Dennison Corporation
7.1.1 Avery Dennison Corporation Company Information
7.1.2 Avery Dennison Corporation Introduction and Business Overview
7.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Avery Dennison Corporation Antiviral Drug Packaging Product Offerings
7.1.5 Avery Dennison Corporation Recent Development
7.2 E.I. du Pont de Nemours
7.2.1 E.I. du Pont de Nemours Company Information
7.2.2 E.I. du Pont de Nemours Introduction and Business Overview
7.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.2.4 E.I. du Pont de Nemours Antiviral Drug Packaging Product Offerings
7.2.5 E.I. du Pont de Nemours Recent Development
7.3 CCL Industries Inc
7.3.1 CCL Industries Inc Company Information
7.3.2 CCL Industries Inc Introduction and Business Overview
7.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.3.4 CCL Industries Inc Antiviral Drug Packaging Product Offerings
7.3.5 CCL Industries Inc Recent Development
7.4 BioCote
7.4.1 BioCote Company Information
7.4.2 BioCote Introduction and Business Overview
7.4.3 BioCote Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.4.4 BioCote Antiviral Drug Packaging Product Offerings
7.4.5 BioCote Recent Development
7.5 Avient
7.5.1 Avient Company Information
7.5.2 Avient Introduction and Business Overview
7.5.3 Avient Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Avient Antiviral Drug Packaging Product Offerings
7.5.5 Avient Recent Development
7.6 Mondi
7.6.1 Mondi Company Information
7.6.2 Mondi Introduction and Business Overview
7.6.3 Mondi Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Mondi Antiviral Drug Packaging Product Offerings
7.6.5 Mondi Recent Development
7.7 Biomaster
7.7.1 Biomaster Company Information
7.7.2 Biomaster Introduction and Business Overview
7.7.3 Biomaster Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Biomaster Antiviral Drug Packaging Product Offerings
7.7.5 Biomaster Recent Development
7.8 BASF
7.8.1 BASF Company Information
7.8.2 BASF Introduction and Business Overview
7.8.3 BASF Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.8.4 BASF Antiviral Drug Packaging Product Offerings
7.8.5 BASF Recent Development
7.9 Lonza
7.9.1 Lonza Company Information
7.9.2 Lonza Introduction and Business Overview
7.9.3 Lonza Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Lonza Antiviral Drug Packaging Product Offerings
7.9.5 Lonza Recent Development
7.10 Takex Labo Co. Ltd
7.10.1 Takex Labo Co. Ltd Company Information
7.10.2 Takex Labo Co. Ltd Introduction and Business Overview
7.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Takex Labo Co. Ltd Antiviral Drug Packaging Product Offerings
7.10.5 Takex Labo Co. Ltd Recent Development
7.11 Berry
7.11.1 Berry Company Information
7.11.2 Berry Introduction and Business Overview
7.11.3 Berry Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Berry Antiviral Drug Packaging Product Offerings
7.11.5 Berry Recent Development
7.12 Lageen Tubes.
7.12.1 Lageen Tubes. Company Information
7.12.2 Lageen Tubes. Introduction and Business Overview
7.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Lageen Tubes. Antiviral Drug Packaging Product Offerings
7.12.5 Lageen Tubes. Recent Development
8 Industry Chain Analysis
8.1 Antiviral Drug Packaging Industrial Chain
8.2 Antiviral Drug Packaging Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Antiviral Drug Packaging Sales Model
8.5.2 Sales Channel
8.5.3 Antiviral Drug Packaging Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Avery Dennison Corporation
E.I. du Pont de Nemours
CCL Industries Inc
BioCote
Avient
Mondi
Biomaster
BASF
Lonza
Takex Labo Co. Ltd
Berry
Lageen Tubes.
*If Applicable.